Pulmonx Corporation
LUNG·Stocks·Medical Specialties·United States·Nasdaq·USD
Price
$1.86
Today
+1.6%
YTD
-16.1%
About
Pulmonx Corporation is a commercial-stage medical technology company primarily engaged in the provision of pulmonology technology, planning tools, and treatments for obstructive lung disease. Founded in 1998, the firm is headquartered in Redwood City, California, and is listed on the NASDAQ GS under the ticker LUNG. Add this instrument to your eToro watchlist to track the LUNG price chart.
Price chart
Closing price history for LUNG (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.58
P/S (TTM)0.89
P/B (TTM)2.01
Market cap$78.60M
Cap tierMicro-cap
Industry avg P/E17.08
Profitability
Gross margin76.71%
EBIT margin-52.96%
Net margin-44.30%
ROE-88.87%
ROA-36.74%
Earnings & Revenue
Revenue (TTM)$87.44M
Revenue growth (1Y)-3.4%
EPS (TTM)-$1.16
Free cash flow$-31.15M
Total debt$56.21M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.25
Employees296
Next earnings11 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.